Jacobs Levy Equity Management
ALNA

Jacobs Levy Equity Management’s Allena Pharmaceuticals ALNA Stock Holding History

Jacobs Levy Equity Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-222,381
Closed -$329K – 1119
2020
Q3 		$329K Buy
222,381
+95,709
+76% +$134K ﹤0.01% 875
2020
Q2 		$200K Sell
126,672
-50,102
-28% -$84.2K ﹤0.01% 956
2020
Q1 		$170K Buy
+176,774
New +$354K ﹤0.01% 909
2019
Q3 		– Sell
-41,587
Closed -$169K – 1028
2019
Q2 		$169K Buy
41,587
+6,030
+17% +$32.9K ﹤0.01% 888
2019
Q1 		$250K Buy
+35,557
New +$258K ﹤0.01% 864

Other funds holding ALNA

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Jacobs Levy Equity Management's ALNA Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of Allena Pharmaceuticals (ALNA) in Q4 2020, closing a stake of 222,381 shares — an estimated $329K sold.

Jacobs Levy Equity Management first reported a position in ALNA in Q1 2019 and held it in 5 quarters. The position peaked at $329K in Q3 2020. 28 funds tracked by Wall St. Rank hold ALNA as of Q4 2020.

  • Jacobs Levy Equity Management reported no remaining Allena Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 222,381 Allena Pharmaceuticals shares in Q4 2020, an estimated $329K.
  • Jacobs Levy Equity Management first reported a position in Allena Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Jacobs Levy Equity Management's Allena Pharmaceuticals position peaked at $329K in Q3 2020.
  • 28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.